Insider · CIK 0001797818
Christine Zedelmayer
Files at EQ (Equillium, Inc.). First filing Oct 30, 2024, latest Jun 5, 2026.
In brief
Christine Zedelmayer files SEC Form 4 as COO at EQ (Equillium, Inc.). Since Oct 30, 2024, Christine Zedelmayer has reported 0 open-market buys worth $0 and 10 open-market sells worth $1.9M, the latest filed on Jun 5, 2026.
A track record needs three past buys with six months of prices behind them; Christine Zedelmayer has 0, so none is measured yet.
The newest scored trade: sold $43k of EQ on Jun 5, 2026, filed Jun 5, 2026, scored 11 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 9 sells worth $1.8M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EQ: Equillium, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 11Weak | Equillium, Inc. | $43k 14,584 shares | -19% | +914% from low-7% from high | |
| 33Weak | Equillium, Inc. | $267k 95,833 shares | -132% | +807% from low0% from high | |
| 19Weak | Equillium, Inc. | $301k 120,312 shares | -66% | +752% from low0% from high | |
| 20Weak | Equillium, Inc. | $362k 181,219 shares | -74% | +597% from low0% from high | |
| 20Weak | Equillium, Inc. | $328k 185,937 shares | -93% | +528% from low-9% from high | |
| 20Weak | Equillium, Inc. | $328k 185,937 shares | -62% | +528% from low-9% from high | |
| 16Weak | Equillium, Inc. | $150k 100,000 shares | -52% | +366% from low-32% from high | |
| 16Weak | Equillium, Inc. | $47k 35,704 shares | -28% | +341% from low-36% from high | |
| 0Weak | Equillium, Inc. | $7,696 8,098 shares | -6% | +221% from low-53% from high | |
| 8Weak | Equillium, Inc. | $19k 15,000 shares | -10% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| May 27, 2026 | EQ Equillium, Inc. | 65,625 0.10% of outstanding | $173k | May 27, 2026 | $357k |
| Mar 13, 2026 | EQ Equillium, Inc. | 120,312 0.20% of outstanding | $289k | Mar 13, 2026 | $695k |
| Mar 9, 2026 | EQ Equillium, Inc. | 181,219 0.30% of outstanding | $321k | Mar 9, 2026 | $378k |
| Feb 19, 2026 | EQ Equillium, Inc. | 185,937 0.31% of outstanding | $316k | Feb 19, 2026 | $205k |
| Dec 23, 2025 | EQ Equillium, Inc. | 100,000 0.16% of outstanding | $150k | Dec 23, 2025 | $55k |
| Dec 12, 2025 | EQ Equillium, Inc. | 23,804 0.04% of outstanding | $32k | Dec 12, 2025 | $7,696 |
| Nov 25, 2025 | EQ Equillium, Inc. | 8,098 0.01% of outstanding | $7,428 | Nov 25, 2025 | none |
| Oct 31, 2024 | EQ Equillium, Inc. | 15,000 0.04% of outstanding | $19k | Oct 28, 2024 | none |
Transactions
The newest 50 of 60 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | EQ Equillium, Inc. | MOption exercise Common Stock10b5-1 | +14,584 | $0.79 | $11k | 77,170 | Jun 5, 2026 |
| Jun 5, 2026 | EQ Equillium, Inc. | SOpen-market sale Common Stock10b5-1 | -14,584 | $2.93 | $43k | 62,586 | Jun 5, 2026 |
| Jun 5, 2026 | EQ Equillium, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -14,584 | $0.00 | $0 | 25,521 | Jun 5, 2026 |
| May 27, 2026 | EQ Equillium, Inc. | MOption exercise Common Stock10b5-1 | +9,821 | $0.77 | $7,562 | 72,407 | May 29, 2026 |
| May 27, 2026 | EQ Equillium, Inc. | SOpen-market sale Common Stock10b5-1 | -9,821 | $2.70 | $27k | 62,586 | May 29, 2026 |
| May 28, 2026 | EQ Equillium, Inc. | MOption exercise Common Stock10b5-1 | +7,292 | $0.73 | $5,323 | 69,878 | May 29, 2026 |
| May 28, 2026 | EQ Equillium, Inc. | MOption exercise Common Stock10b5-1 | +48,512 | $0.77 | $37k | 118,390 | May 29, 2026 |
| May 28, 2026 | EQ Equillium, Inc. | SOpen-market sale Common Stock10b5-1 | -55,604 | $2.70 | $150k | 62,786 | May 29, 2026 |
| May 28, 2026 | EQ Equillium, Inc. | SOpen-market sale Common Stock10b5-1 | -200 | $2.71 | $542 | 62,586 | May 29, 2026 |
| May 28, 2026 | EQ Equillium, Inc. | MOption exercise Common Stock10b5-1 | +14,583 | $0.79 | $11k | 77,169 | May 29, 2026 |
| May 28, 2026 | EQ Equillium, Inc. | MOption exercise Common Stock10b5-1 | +15,625 | $0.79 | $12k | 92,794 | May 29, 2026 |
| May 28, 2026 | EQ Equillium, Inc. | SOpen-market sale Common Stock10b5-1 | -30,208 | $2.98 | $90k | 62,586 | May 29, 2026 |
| May 27, 2026 | EQ Equillium, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -9,821 | $0.00 | $0 | 165,179 | May 29, 2026 |
| May 28, 2026 | EQ Equillium, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -7,292 | $0.00 | $0 | 91,146 | May 29, 2026 |
| May 28, 2026 | EQ Equillium, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -48,512 | $0.00 | $0 | 116,667 | May 29, 2026 |
| May 28, 2026 | EQ Equillium, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -14,583 | $0.00 | $0 | 40,105 | May 29, 2026 |
| May 28, 2026 | EQ Equillium, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -15,625 | $0.00 | $0 | 0 | May 29, 2026 |
| Mar 13, 2026 | EQ Equillium, Inc. | MOption exercise Common Stock10b5-1 | +120,312 | $0.79 | $94k | 182,898 | Mar 16, 2026 |
| Mar 13, 2026 | EQ Equillium, Inc. | SOpen-market sale Common Stock10b5-1 | -120,312 | $2.50 | $301k | 62,586 | Mar 16, 2026 |
| Mar 13, 2026 | EQ Equillium, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -120,312 | $0.00 | $0 | 54,688 | Mar 16, 2026 |
| Feb 19, 2026 | EQ Equillium, Inc. | MOption exercise Common Stock10b5-1 | +109,375 | $0.79 | $86k | 200,819 | Mar 11, 2026 |
| Mar 9, 2026 | EQ Equillium, Inc. | MOption exercise Common Stock10b5-1 | +35,695 | $0.79 | $28k | 127,139 | Mar 11, 2026 |
| Feb 19, 2026 | EQ Equillium, Inc. | SOpen-market sale Common Stock10b5-1 | -109,375 | $1.78 | $195k | 91,444 | Mar 11, 2026 |
| Mar 9, 2026 | EQ Equillium, Inc. | MOption exercise Common Stock10b5-1 | +41,666 | $0.79 | $33k | 168,805 | Mar 11, 2026 |
| Feb 19, 2026 | EQ Equillium, Inc. | MOption exercise Common Stock10b5-1 | +76,562 | $0.73 | $56k | 168,006 | Mar 11, 2026 |
| Mar 9, 2026 | EQ Equillium, Inc. | MOption exercise Common Stock10b5-1 | +75,000 | $0.79 | $59k | 243,805 | Mar 11, 2026 |
| Feb 19, 2026 | EQ Equillium, Inc. | SOpen-market sale Common Stock10b5-1 | -76,562 | $1.74 | $133k | 91,444 | Mar 11, 2026 |
| Mar 9, 2026 | EQ Equillium, Inc. | SOpen-market sale Common Stock10b5-1 | -181,219 | $2.00 | $362k | 62,586 | Mar 11, 2026 |
| Mar 9, 2026 | EQ Equillium, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -35,695 | $0.00 | $0 | 0 | Mar 11, 2026 |
| Mar 9, 2026 | EQ Equillium, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -41,666 | $0.00 | $0 | 0 | Mar 11, 2026 |
| Mar 9, 2026 | EQ Equillium, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -75,000 | $0.00 | $0 | 0 | Mar 11, 2026 |
| Feb 19, 2026 | EQ Equillium, Inc. | MOption exercise Common Stock10b5-1 | +109,375 | $0.79 | $86k | 300,819 | Feb 23, 2026 |
| Feb 19, 2026 | EQ Equillium, Inc. | SOpen-market sale Common Stock10b5-1 | -109,375 | $1.78 | $195k | 191,444 | Feb 23, 2026 |
| Feb 19, 2026 | EQ Equillium, Inc. | MOption exercise Common Stock10b5-1 | +76,562 | $0.73 | $56k | 268,006 | Feb 23, 2026 |
| Feb 19, 2026 | EQ Equillium, Inc. | SOpen-market sale Common Stock10b5-1 | -76,562 | $1.74 | $133k | 191,444 | Feb 23, 2026 |
| Feb 19, 2026 | EQ Equillium, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -109,375 | $0.00 | $0 | 15,625 | Feb 23, 2026 |
| Feb 19, 2026 | EQ Equillium, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -76,562 | $0.00 | $0 | 98,438 | Feb 23, 2026 |
| Jan 7, 2026 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +500,000 | $0.00 | $0 | 500,000 | Jan 9, 2026 |
| Dec 23, 2025 | EQ Equillium, Inc. | MOption exercise Common Stock10b5-1 | +100,000 | $0.79 | $79k | 191,444 | Dec 23, 2025 |
| Dec 23, 2025 | EQ Equillium, Inc. | SOpen-market sale Common Stock10b5-1 | -100,000 | $1.50 | $150k | 91,444 | Dec 23, 2025 |
| Dec 23, 2025 | EQ Equillium, Inc. | MOption exercise Employee Stock Option (right to buy)derivative10b5-1 | -100,000 | $0.00 | $0 | 0 | Dec 23, 2025 |
| Dec 12, 2025 | EQ Equillium, Inc. | SOpen-market sale Common Stock10b5-1 | -23,804 | $1.34 | $32k | 103,344 | Dec 15, 2025 |
| Dec 15, 2025 | EQ Equillium, Inc. | SOpen-market sale Common Stock10b5-1 | -11,900 | $1.31 | $16k | 91,444 | Dec 15, 2025 |
| Nov 25, 2025 | EQ Equillium, Inc. | SOpen-market sale Common Stock10b5-1 | -100 | $0.98 | $98 | 135,146 | Nov 25, 2025 |
| Nov 25, 2025 | EQ Equillium, Inc. | SOpen-market sale Common Stock10b5-1 | -7,998 | $0.95 | $7,598 | 127,148 | Nov 25, 2025 |
| Aug 29, 2025 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +725,000 | $0.00 | $0 | 725,000 | Sep 3, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +35,695 | - | - | 35,695 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -35,695 | - | - | 0 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +41,666 | - | - | 41,666 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -41,666 | - | - | 0 | Feb 19, 2025 |
Questions about Christine Zedelmayer
Answered from the filings on this page, as of the latest one.
Is Christine Zedelmayer buying or selling?
In the last 12 months Christine Zedelmayer reported 0 open-market buys worth $0 and 9 open-market sells worth $1.8M on SEC Form 4; the latest was sold $43k of EQ on Jun 5, 2026. Grants, option exercises and tax withholding are not counted.
How did Christine Zedelmayer's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christine Zedelmayer has 0.
Where does Christine Zedelmayer file Form 4?
Christine Zedelmayer has filed Form 4 at EQ (Equillium, Inc.) as Sr. Vice President and COO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.